Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News
Maternal intestinal, genitourinary infections raise risk for biliary atresia in offspring
Offspring born to mothers with prenatal or third trimester intestinal infection or genitourinary tract infection experienced a significantly higher risk for biliary atresia, according to a study in JAMA Network Open.
CRC incidence significantly higher among patients with cryptogenic pyogenic liver abscess
Patients diagnosed with cryptogenic pyogenic liver abscess had a “significantly higher incidence” of colorectal cancer up to 3 years from diagnosis compared with matched controls, highlighting the importance of CRC screening, data showed.
Log in or Sign up for Free to view tailored content for your specialty!
Use of beta-blockers linked to acute kidney injury, mortality in decompensated cirrhosis
Use of nonselective beta-blockers was associated with stage 2 acute kidney injury and all-cause mortality among patients with decompensated cirrhosis waitlisted for liver transplantation, data showed.
Dry January campaign aims to make ‘first step’ toward abstinence less daunting
Each January, Alcohol Change UK runs Dry January, a post-holiday campaign that encourages people to abstain from alcohol for 31 days at the beginning of the year and drink more healthily year-round.
‘Age should not be a contraindication’ for liver transplant in older patients with ACLF
Older adult patients with acute-on-chronic liver failure had significantly higher waitlist mortality but “acceptable” 1-year survival after liver transplantation, according to data in Clinical Gastroenterology and Hepatology.
Less than 25% of patients with cirrhosis, low bone density are treated for osteoporosis
Patients with cirrhosis are less frequently screened for osteoporosis compared with the general population, and less than 25% with low bone density actually receive treatment, according to research in Alimentary Pharmacology & Therapeutics.
VIDEO: Investigational FGF-21 improves liver fat, glycemic control markers in MASH, diabetes
BOSTON — In this video, Rohit Loomba, MD, MHSc, discusses data supporting once-monthly dosing of BOS-580, an investigational, long-acting fibroblast growth factor-21 analog for treatment of metabolic dysfunction-associated steatohepatitis.
VIDEO: Unmet need in ACLF presents ‘very large opportunity’ for new technology
In this Healio video exclusive, Dean Hum, PhD, chief scientific officer at Genfit, outlines five ongoing programs in the company’s acute-on-chronic liver failure development pipeline, which recently were presented at The Liver Meeting.
ACG publishes new guideline for management of alcohol-associated liver disease
A new clinical guideline published in the American Journal of Gastroenterology underscored the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with alcohol-associated liver disease.
Guideline rewind: 10 clinical updates that revamped GI, hepatology practice in 2023
Throughout 2023, gastroenterology societies made several significant clinical practice updates to guide diagnosis, management and treatment of various GI disorders such as celiac disease, inflammatory bowel disease and acute liver failure.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read